Arnold & Porter

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Firms: transactions

Complex transactions involving state-of-the-art technologies are meat and drink to the IP group at Arnold & Porter Kaye Scholer: as examples, in 2020 it advised both AstraZeneca and Pfizer on their covid-19 vaccines. Running point for both was Ewan Townsend, who made partner in January 2020 and is a walking encyclopaedia of pharmaceutical regulatory know-how. “Ewan’s work is always outstanding and his commercial acumen is excellent. He is a pleasure to work with and extremely responsive.” His counterpart on the disputes side is Beatriz San Martin, another life sciences expert who has been tasked with building out the firm’s contentious IP offering. She recently acted for Sandoz in a protracted, high-profile SPC invalidity case.

Get unlimited access to all IAM content